Table 3.
Summary of typhoid vaccine economic evaluation types.
| Characteristic | Number of studies (n = 7) | Reference |
|---|---|---|
| Based on field studies | 5 | [27], [28], [29], [30], [31] |
| Perspective: | ||
| Public sector only | 2 | [27], [32] |
| Private only | 1 | [29] |
| Societal (public and private) | 4 | [28], [29], [30], [31], [33] |
| Include intangible costs of pain, suffering and disability | 3 | [28], [30] |
| Analytical approach: (a study can include more than one approach) | ||
| Cost-benefit analysis component | 4 | [29], [30], [31], [32] |
| Cost-effectiveness analysis component | 2 | [27], [32] |
| Cost-utility analysis component | 2 | [30], [33] |
| Willingness-to-pay component | 4 | [27], [28], [29] |
| Price-optimisation model | 1 | [27] |
| Include indirect protection of vaccines | 1 | [27] |
| Include transmission dynamics | 0 | |
| Evaluates improve sanitation, hygiene or water supply as an alternative to or adjunct to vaccination | 0 | |